Oragenics, Inc. (NYSE:OGEN) ("Oragenics" or the "Company"), a biotechnology company dedicated to fighting infectious diseases including COVID-19, announces the appointment of Janet Huffman as
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a disruptor in bloodstream infection identification and susceptibility testing today announced the appointment of Hany Massarany to chairman of the company's board of
The Company aims for a leaner organization with a primary focus on achieving profitability in 2023 and approximately CAD$3.5 million in annualized cost savings
TORONTO and GLIL
The U.S. Securities and Exchange Commission (SEC) announced that public companies will soon be required to reveal crucial metrics linking financial performance and CEO pay.
Ignore Bistricer/Murchinson Ltd.'s Misinformation Campaign
Disregard Murchinson/Bistricer Proxy Voting Materials
No Shareholder Action Is Required at This Time
Company Will Inform Shareholders If and When a